Львівський Національний Медичний Університет Імені Данила Галицького
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Львівський Національний Медичний Університет Імені Данила ГалицькогоfiledCriticalЛьвівський Національний Медичний Університет Імені Данила Галицького
Priority to UAU201001910UpriorityCriticalpatent/UA52396U/en
Publication of UA52396UpublicationCriticalpatent/UA52396U/en
An agent with mexidol for treatment of parodentium pathology oral cavity mucous membrane contains mexidol 5 %. Mexidol 5 % is included into composition of film-carrier of polymeric type, containing sodium carboxymethylcellulose, polyvinyl alcohol, polyethylenglycol, glycerin, Tween-80, saccharin and treated water.
UAU201001910U2010-02-222010-02-22agent with mexidol for treatment of parodentium pathology oral cavity mucous membrane as polymeric film
UA52396U
(en)
Tool that has the ability to stimulate reparative processes of periodontal tissues, as well as an antioxidant and anti-inflammatory effect, which is a 2-ethyl-6-methyl-3-hydroxypyridia-2- (3-benzoilphenil)-propanoate, and a pharmaceutical composition based on it
Tool that has the ability to stimulate reparative processes of periodontal tissues, as well as an antioxidant and anti-inflammatory effect, which is a 2-ethyl-6-methyl-3-hydroxypyridia-2- (3-benzoilphenil)-propanoate, and a pharmaceutical composition based on it